Bianca Sanger
Overview
Explore the profile of Bianca Sanger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
811
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beguir K, Skwark M, Fu Y, Pierrot T, Lopez Carranza N, Laterre A, et al.
Comput Biol Med
. 2023 Feb;
155:106618.
PMID: 36774893
The ongoing COVID-19 pandemic is leading to the discovery of hundreds of novel SARS-CoV-2 variants daily. While most variants do not impact the course of the pandemic, some variants pose...
2.
Muik A, Adams 3rd H, Gieseke F, Altintas I, Schoedel K, Blum J, et al.
J Immunother Cancer
. 2022 Jun;
10(6).
PMID: 35688554
Background: Despite the preclinical promise of CD40 and 4-1BB as immuno-oncology targets, clinical efforts evaluating CD40 and 4-1BB agonists as monotherapy have found limited success. DuoBody-CD40×4-1BB (GEN1042/BNT312) is a novel...
3.
Muik A, Garralda E, Altintas I, Gieseke F, Geva R, Ben-Ami E, et al.
Cancer Discov
. 2022 Feb;
12(5):1248-1265.
PMID: 35176764
Significance: DuoBody-PD-L1×4-1BB (GEN1046) is a first-in-class bispecific immunotherapy with a manageable safety profile and encouraging preclinical and early clinical activity. With its ability to confer clinical benefit in tumors typically...
4.
Vogel A, Kanevsky I, Che Y, Swanson K, Muik A, Vormehr M, et al.
Nature
. 2021 Feb;
592(7853):283-289.
PMID: 33524990
A safe and effective vaccine against COVID-19 is urgently needed in quantities that are sufficient to immunize large populations. Here we report the preclinical development of two vaccine candidates (BNT162b1...
5.
Muik A, Wallisch A, Sanger B, Swanson K, Muhl J, Chen W, et al.
Science
. 2021 Jan;
371(6534):1152-1153.
PMID: 33514629
Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage called B.1.1.7 (variant of concern: VOC 202012/01), which is reported to spread more efficiently and faster than other strains,...